Which Chemotherapy Drugs Are Used for Ampullary Cancer?

This page focuses on adjuvant chemotherapy—treatment given after surgery to reduce the risk of the cancer returning. Because ampullary cancer is rare, most treatment guidelines are extrapolated from research on colon and pancreatic cancers ^[1]. Adjuvant chemotherapy is not mandatory for everyone; depending on your tumor’s stage and your overall health, your doctor might recommend close observation instead of systemic treatment ^[2].

If you have advanced, recurrent, or metastatic disease, your treatment options will differ and may include targeted therapies, immunotherapies, or clinical trials rather than standard adjuvant treatments.

If your oncology team recommends adjuvant chemotherapy, the specific drugs they choose will depend heavily on your tumor’s histological subtype (what the cells look like under a microscope), your cancer stage, and your overall fitness ^{[3] [4]}.

Regimens for the Intestinal Subtype

Intestinal-type ampullary tumors behave similarly to colon cancer. Guidelines generally recommend treatments based on fluorouracil (5-FU) or capecitabine, an oral medication that the body converts into 5-FU ^[3].

Common multi-drug combinations include:

• FOLFOX: A combination of 5-FU, leucovorin (a medication that enhances 5-FU), and oxaliplatin ^[3].
• CAPOX: A combination of capecitabine pills and intravenous oxaliplatin ^[3].

If your team recommends one of these regimens, treatment usually lasts between 3 and 6 months depending on your recurrence risk and how well you tolerate the drugs ^[3].

Regimens for the Pancreatobiliary and Mixed Subtypes

Pancreatobiliary-type tumors share characteristics with pancreatic cancer. Mixed subtypes contain both intestinal and pancreatobiliary features. They are often treated similarly to the pancreatobiliary type, though your doctor will individualize your plan based on expert review ^[3].

Common regimens include:

• mFOLFIRINOX: An intensive combination of 5-FU, leucovorin, irinotecan, and oxaliplatin ^[3]. This is generally planned for about 6 months, but it requires adequate kidney and liver function and is typically reserved for patients likely to tolerate heavy side effects ^[4].
• Gemcitabine-based regimens: Gemcitabine given alone or combined with capecitabine ^[3]. These courses also typically last around 6 months ^[4].

Single-Drug Options (Monotherapy)

Intensive multi-drug regimens are not the right fit for everyone. If conditions like frailty, kidney issues, or other health problems make combination therapy too risky, your doctor might recommend a single drug ^[4]. Common options for this approach include gemcitabine, 5-FU, or capecitabine ^[4].

Common Side Effects to Watch For

Every chemotherapy drug has a different side effect profile. You should discuss what to expect with your team, but general side effects include:

• Oxaliplatin (found in FOLFOX, CAPOX, and mFOLFIRINOX): Nerve pain or tingling (neuropathy) and extreme sensitivity to cold temperatures.
• 5-FU and Capecitabine: Diarrhea, mouth sores, and hand-foot syndrome (redness, pain, and peeling on the palms and soles).
• Irinotecan (found in mFOLFIRINOX): Significant diarrhea and low blood counts.
• Gemcitabine: Low blood cell counts and fatigue.

Always ask your oncology clinic for an emergency contact number. Call them immediately if you experience a fever of 100.4°F (38°C) or higher, uncontrolled diarrhea or vomiting, signs of dehydration, or difficulty breathing.